EndoChoice receives "strong buy" rating from analysts: 4 points

EndoChoice stock has earned a "strong buy" rating from four analysts, according to a Storm Investor report.

Here are four points:

1. Analysts have set a 12-month consensus target price of $19.67 for the stock.

2. EndoChoice has a 12-month low of $7.37 and a 12-month high of $19.69.

3. The firm has a 50-day moving average of $8.92 and a 200-day moving average of $13.40.

4. The stock's market cap is $205.05 million.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast